Capital Counsel’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.98M Buy
50,205
+13,125
+35% +$519K 0.08% 25
2025
Q1
$1.12M Hold
37,080
0.05% 30
2024
Q4
$1.3M Hold
37,080
0.06% 29
2024
Q3
$1.49M Hold
37,080
0.06% 28
2024
Q2
$1.77M Sell
37,080
-2,500
-6% -$119K 0.08% 26
2024
Q1
$1.72M Sell
39,580
-500
-1% -$21.7K 0.08% 25
2023
Q4
$2.03M Sell
40,080
-150
-0.4% -$7.59K 0.1% 24
2023
Q3
$1.82M Hold
40,230
0.1% 25
2023
Q2
$1.65M Hold
40,230
0.09% 26
2023
Q1
$1.44M Hold
40,230
0.08% 27
2022
Q4
$1.52M Hold
40,230
0.1% 24
2022
Q3
$1.78M Sell
40,230
-780
-2% -$34.5K 0.12% 22
2022
Q2
$1.52M Hold
41,010
0.09% 24
2022
Q1
$1.52M Buy
41,010
+430
+1% +$15.9K 0.07% 27
2021
Q4
$1.24M Hold
40,580
0.05% 30
2021
Q3
$1.36M Hold
40,580
0.07% 28
2021
Q2
$1.62M Sell
40,580
-1,500
-4% -$59.8K 0.08% 27
2021
Q1
$1.89M Hold
42,080
0.11% 24
2020
Q4
$2.38M Hold
42,080
0.14% 20
2020
Q3
$2M Buy
42,080
+2,700
+7% +$128K 0.13% 21
2020
Q2
$2.32M Hold
39,380
0.17% 21
2020
Q1
$1.86M Hold
39,380
0.15% 23
2019
Q4
$2.38M Hold
39,380
0.16% 26
2019
Q3
$2.36M Hold
39,380
0.17% 25
2019
Q2
$2.53M Sell
39,380
-5,000
-11% -$321K 0.17% 26
2019
Q1
$3.6M Buy
44,380
+1,000
+2% +$81.2K 0.26% 25
2018
Q4
$2.35M Hold
43,380
0.19% 25
2018
Q3
$2.24M Hold
43,380
0.16% 29
2018
Q2
$1.81M Buy
43,380
+1,000
+2% +$41.7K 0.14% 27
2018
Q1
$1.87M Buy
42,380
+1,100
+3% +$48.5K 0.15% 27
2017
Q4
$2.08M Hold
41,280
0.17% 28
2017
Q3
$2.09M Hold
41,280
0.19% 27
2017
Q2
$2.1M Buy
41,280
+3,250
+9% +$165K 0.19% 27
2017
Q1
$1.53M Buy
38,030
+500
+1% +$20.1K 0.15% 31
2016
Q4
$1.8M Hold
37,530
0.19% 29
2016
Q3
$1.38M Buy
37,530
+9,000
+32% +$330K 0.12% 30
2016
Q2
$664K Buy
28,530
+10,100
+55% +$235K 0.06% 35
2016
Q1
$746K Buy
18,430
+430
+2% +$17.4K 0.07% 34
2015
Q4
$1.12M Buy
18,000
+5,000
+38% +$310K 0.06% 53
2015
Q3
$525K Hold
13,000
0.03% 70
2015
Q2
$748K Hold
13,000
0.04% 66
2015
Q1
$828K Hold
13,000
0.04% 63
2014
Q4
$803K Hold
13,000
0.04% 67
2014
Q3
$505K Buy
13,000
+1,000
+8% +$38.8K 0.03% 78
2014
Q2
$413K Buy
+12,000
New +$413K 0.02% 87